Country: Sweden
Language: Swedish
Source: Läkemedelsverket (Medical Products Agency)
amlodipinbesilat; hydroklortiazid; valsartan
Teva B.V.
C09DX01
amlodipinbesilat; hydrochlorothiazide; valsartan
10 mg/ 160 mg/ 12,5 mg
Filmdragerad tablett
laktosmonohydrat Hjälpämne; valsartan 160 mg Aktiv substans; hydroklortiazid 12,5 mg Aktiv substans; amlodipinbesilat 13,86 mg Aktiv substans
Receptbelagt
Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter
Avregistrerad
2020-04-15
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Valtensam Comp 10 mg/160 mg/12.5 mg film-coated tablets Valtensam Comp 5 mg/160 mg/25 mg film-coated tablets Valtensam Comp 10 mg/160 mg/25 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION [Product name] 10 mg/160 mg/12.5 mg film-coated tablets Each film-coated tablet contains amlodipine besilate equivalent to 10 mg amlodipine, 160 mg of valsartan, and 12.5 mg of hydrochlorothiazide. [Product name] 5 mg/160 mg/25 mg film-coated tablets Each film-coated tablet containsamlodipine besilate equivalent to 5 mg amlodipine, 160 mg of valsartan, and 25 mg of hydrochlorothiazide. [Product name] 10 mg/160 mg/25 mg film-coated tablets Each film-coated tablet containsamlodipine besilate equivalent to 10 mg amlodipine, 160 mg of valsartan, and 25 mg of hydrochlorothiazide. Excipient(s) with known effect [Product name] 10 mg/160 mg/12.5 mg film-coated tablets Each tablet contains 5 mg of lactose. [Product name] 5 mg/160 mg/25 mg film-coated tablets Each tablet contains 5 mg of lactose. [Product name] 10 mg/160 mg/25 mg film-coated tablets Each tablet contains 5 mg of lactose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet (tablet) [Product name] 10 mg/160 mg/12.5 mg film-coated tablets Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled edges, with debossing VIL on one side of the tablet. [Product name] 5 mg/160 mg/25 mg film-coated tablets Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled edges, with debossing VIH on one side of the tablet [Product name] 10 mg/160 mg/25 mg film-coated tablets Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled edges, with debossing VIT on one side of the tablet. 2 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (HCT), Read the complete document